Eulerpool Terminal
The edge that pays for itself.
Current Transcode Therapeutics forecasts and price targets in October 2026
Ø Analyst Price Targets
3.06 USD
+65.85 %
Median
3.06 USD
+65.85 %
Max
3.15 USD
Min
3.03 USD
Last Price
1.85 USD
Buy
6
Hold
1
Sell
0
The average target price for Transcode Therapeutics is 3.06 USD. (+65.85 % above the current price)
The median price target of Transcode Therapeutics is 3.06 USD.
Stock analysts from many renowned investment banks are closely examining the Transcode Therapeutics stock. They conclude their professional Transcode Therapeutics stock analyses with a clear recommendation for the Transcode Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2025-06-01 | 6 | 1 | 0 | — |
| 2025-05-01 | 6 | 1 | 0 | — |
| 2025-04-01 | 6 | 1 | 0 | — |
| 2025-03-01 | 6 | 1 | 0 | — |
| 2025-02-01 | 6 | 1 | 0 | — |
| 2025-01-01 | 6 | 1 | 0 | — |
Transcode Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Transcode Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2028e | 10.00 M USD | — | — |
| 2029e | 28.00 M USD | — | — |
| 2030e | 52.00 M USD | — | — |